These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 11572107)

  • 1. [Incompatibility of olanzapine and amisulpride in multisystemic myotonic myopathy].
    Pedrosa Gil F; Schneider C; Grohmann R; Rüther E
    Nervenarzt; 2001 Sep; 72(9):729-33. PubMed ID: 11572107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intolerance to neuroleptics and susceptibility for malignant hyperthermia in a patient with proximal myotonic myopathy (PROMM) and schizophrenia.
    Schneider C; Pedrosa Gil F; Schneider M; Anetseder M; Kress W; Müller CR
    Neuromuscul Disord; 2002 Jan; 12(1):31-5. PubMed ID: 11731282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tardive dyskinesias and antipsychotics: a review.
    Llorca PM; Chereau I; Bayle FJ; Lancon C
    Eur Psychiatry; 2002 May; 17(3):129-38. PubMed ID: 12052573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluphenazine (oral) versus atypical antipsychotics for schizophrenia.
    Sampford JR; Sampson S; Li BG; Zhao S; Xia J; Furtado VA
    Cochrane Database Syst Rev; 2016 Jul; 7(7):CD010832. PubMed ID: 27370402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Plasma prolactin level and incidence of adverse endocrinologic effects during therapy with atypical neuroleptics].
    Fric M; Laux G
    Psychiatr Prax; 2003 May; 30 Suppl 2():S97-101. PubMed ID: 14509051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Atypical antipsychotics].
    Naber D
    Nervenarzt; 2000 May; 71(5):327-8. PubMed ID: 10846707
    [No Abstract]   [Full Text] [Related]  

  • 7. Do differences in atypical antipsychotics matter in routine practice? Medication switch from olanzapine and risperidone to amisulpride.
    Linden M; Eich FX; Pyrkosch L
    Int Clin Psychopharmacol; 2007 May; 22(3):175-8. PubMed ID: 17414744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comments on "Double-blind comparison of olanzapine versus risperidone in the treatment of schizophrenia and other psychotic disorders" by Tran and Associates.
    Kasper S; Küfferle B
    J Clin Psychopharmacol; 1998 Aug; 18(4):353-6. PubMed ID: 9690709
    [No Abstract]   [Full Text] [Related]  

  • 9. Amisulpride: a review of its use in the management of schizophrenia.
    McKeage K; Plosker GL
    CNS Drugs; 2004; 18(13):933-56. PubMed ID: 15521794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparative effectiveness study of risperidone and olanzapine in the treatment of schizophrenia.
    Ho BC; Miller D; Nopoulos P; Andreasen NC
    J Clin Psychiatry; 1999 Oct; 60(10):658-63. PubMed ID: 10549681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rhabdomyolysis and coma associated with amisulpride: a probable atypical presentation of neuroleptic malignant syndrome.
    Atbasoglu EC; Ozguven HD; Can Saka M; Goker C
    J Clin Psychiatry; 2004 Dec; 65(12):1724-5. PubMed ID: 15641884
    [No Abstract]   [Full Text] [Related]  

  • 12. Marked elevation of serum creatine kinase associated with olanzapine therapy.
    Marcus EL; Vass A; Zislin J
    Ann Pharmacother; 1999 Jun; 33(6):697-700. PubMed ID: 10410183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Olanzapine and sulpiride: a preliminary study of combination/augmentation in patients with treatment-resistant schizophrenia.
    Raskin S; Durst R; Katz G; Zislin J
    J Clin Psychopharmacol; 2000 Oct; 20(5):500-3. PubMed ID: 11001233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Use of atypical antipsychotics in Charles Perrens psychiatric hospital (Bordeaux) analysis of prescribing practices for Amisulpride, Clozapine, Olanzapine and Risperidone].
    Bret P; Bonnet F; Bret MC; Jaffré A
    Encephale; 2002; 28(4):329-42. PubMed ID: 12232542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized double-blind study of risperidone and olanzapine in the treatment of schizophrenia or schizoaffective disorder.
    Conley RR; Mahmoud R
    Am J Psychiatry; 2001 May; 158(5):765-74. PubMed ID: 11329400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of olanzapine and other antipsychotics on cognitive function in chronic schizophrenia: a longitudinal study.
    Cuesta MJ; Peralta V; Zarzuela A
    Schizophr Res; 2001 Mar; 48(1):17-28. PubMed ID: 11278151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [New i.e. atypical neuroleptic agents for negative symptoms of schizophrenia: results and methodological problems of evaluation].
    Möller HJ
    Nervenarzt; 2000 May; 71(5):345-53. PubMed ID: 10846709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroleptic malignant syndrome associated with risperidone and olanzapine in first-episode schizophrenia.
    Aboraya A; Schumacher J; Abdalla E; LePage J; McGhee M; Butcher D; Griffin H; Shahda M
    W V Med J; 2002; 98(2):63-5. PubMed ID: 12048741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes in schizophrenia outpatients treated with amisulpride or olanzapine.
    Hofer A; Rettenbacher MA; Edlinger M; Huber R; Bodner T; Kemmler G; Sachs G; Fleischhacker WW
    Pharmacopsychiatry; 2007 Jan; 40(1):1-8. PubMed ID: 17327953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of risperidone and olanzapine in the control of negative symptoms of chronic schizophrenia and related psychotic disorders in patients aged 50 to 65 years.
    Feldman PD; Kaiser CJ; Kennedy JS; Sutton VK; Tran PV; Tollefson GD; Zhang F; Breier A
    J Clin Psychiatry; 2003 Sep; 64(9):998-1004. PubMed ID: 14628974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.